Meeting
2018 Genitourinary Cancers Symposium
Effect of detecting asymptomatic recurrence after radical cystectomy on prognosis in patients with muscle invasive bladder cancer.
Authors
Shingo Hatakeyama
Hirosaki University Graduate School of Medicine, Hirosaki, Japan
Shingo Hatakeyama , Ayumu Kusaka , Hirotake Kodama , Noriko Tokui , Hayato Yamamoto , Takahiro Yoneyama , Yasuhiro Hashimoto , Takuya Koie , Chikara Ohyama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 428)
DOI
10.1200/JCO.2018.36.6_suppl.428
Abstract #
428
Poster Bd #
F21
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Spatial relationships and immune subsets in the tumor immune microenvironment of head and neck cancers.
First Author: Leanne E. Henry
Poster
2023 ASCO Genitourinary Cancers Symposium
Neural network analysis of tumor and germline profiling to predict survival of muscle-invasive bladder cancer following radical cystectomy: An analysis of the Cancer Genome Atlas (TCGA).
First Author: Guru P. Sonpavde
Poster
2023 ASCO Genitourinary Cancers Symposium
Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC).
First Author: Andrew B Katims
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of care fragmentation in patients receiving neoadjuvant chemotherapy and radical cystectomy for bladder cancer.
First Author: Carlos Riveros